Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

  1. Garassino, M.C.
  2. Gadgeel, S.
  3. Novello, S.
  4. Halmos, B.
  5. Felip, E.
  6. Speranza, G.
  7. Hui, R.
  8. Garon, E.B.
  9. Horinouchi, H.
  10. Sugawara, S.
  11. Rodriguez-Abreu, D.
  12. Reck, M.
  13. Cristescu, R.
  14. Aurora-Garg, D.
  15. Loboda, A.
  16. Lunceford, J.
  17. Kobie, J.
  18. Ayers, M.
  19. Piperdi, B.
  20. Pietanza, M.C.
  21. Paz-Ares, L.
Aldizkaria:
JTO Clinical and Research Reports

ISSN: 2666-3643

Argitalpen urtea: 2023

Alea: 4

Zenbakia: 1

Mota: Artikulua

DOI: 10.1016/J.JTOCRR.2022.100431 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus